P/E ratio for Cooper Companies (COO)
P/E ratio as of May 2024 (TTM): 17.5
According to Cooper Companies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 17.469. At the end of 2022 the company had a P/E ratio of 42.2.
P/E ratio history for Cooper Companies from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 42.2 | 504.05% |
| 2021 | 6.99 | -90.66% |
| 2020 | 74.9 | 120.5% |
| 2019 | 33.9 | -62.19% |
| 2018 | 89.8 | 214.22% |
| 2017 | 28.6 | -7.87% |
| 2016 | 31.0 | -2.94% |
| 2015 | 32.0 | 10.78% |
| 2014 | 28.8 | 42.22% |
| 2013 | 20.3 | 13.49% |
| 2012 | 17.9 | -5.47% |
| 2011 | 18.9 | -16.78% |
| 2010 | 22.7 | 32.9% |
| 2009 | 17.1 | 52.18% |
| 2008 | 11.2 | -107.39% |
| 2007 | -152 | -608.94% |
| 2006 | 29.9 | 17.85% |
| 2005 | 25.3 | 2.11% |
| 2004 | 24.8 | 15.85% |
| 2003 | 21.4 | 37% |
| 2002 | 15.6 | -21.78% |
| 2001 | 20.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 11.0 | -37.15% | 🇺🇸 USA |
 Novartis NVS | 27.4 | 56.99% | 🇨🇭 Switzerland |
 Boston Scientific BSX | 91.0 | 421.13% | 🇺🇸 USA |
 Teleflex TFX | 25.3 | 44.87% | 🇺🇸 USA |
 Utah Medical Products UTMD | 15.0 | -14.22% | 🇺🇸 USA |
 Atrion ATRI | 30.3 | 73.39% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.